Provided By Globe Newswire
Last update: Apr 11, 2022
– Company to present regarding AIM Biologicals as a potential therapeutic treatment option for neuromyelitis optica spectrum disorder ("NMOSD"), an orphan indication with strong unmet medical need
Read more at globenewswire.com